ADDITIONAL COMPLEXITIES IN THE BINDING OF MUSCARINIC RECEPTOR ANTAGONISTS

[1] BIRDSALL NJM, 1978, MOL PHARMACOL, V14, P723

[2] QUATERNARY FORMS OF CLASSICAL MUSCARINIC ANTAGONISTS DISTINGUISH SUBPOPULATIONS OF MUSCARINIC RECEPTORS - CORRELATION WITH GALLAMINE-DEFINED SUBPOPULATIONS [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 126 (03) : 1242 - 1250

[3] EVANS T, 1984, MOL PHARMACOL, V26, P395

[4] FREY KA, 1985, J NEUROSCI, V5, P421

[5] GALPER JB, 1982, J BIOL CHEM, V257, P344

[6] GIBSON RE, 1984, LIFE SCI, V34, P2287, DOI 10.1016/0024-3205(84)90219-4

[7] GOLDSTEIN D, 1985, FED PROC, V44, P1827

[8] HULME EC, 1978, MOL PHARMACOL, V14, P737

[9] LEE JH, 1985, J PHARMACOL EXP THER, V233, P707

[10] ANOMALOUS BINDING OF [H-3] N-METHYLSCOPOLAMINE TO RAT-BRAIN MUSCARINIC RECEPTORS [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 110 (02) : 263 - 266

[1] BIRDSALL NJM, 1978, MOL PHARMACOL, V14, P723

[2] QUATERNARY FORMS OF CLASSICAL MUSCARINIC ANTAGONISTS DISTINGUISH SUBPOPULATIONS OF MUSCARINIC RECEPTORS - CORRELATION WITH GALLAMINE-DEFINED SUBPOPULATIONS [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 126 (03) : 1242 - 1250

[3] EVANS T, 1984, MOL PHARMACOL, V26, P395

[4] FREY KA, 1985, J NEUROSCI, V5, P421

[5] GALPER JB, 1982, J BIOL CHEM, V257, P344

[6] GIBSON RE, 1984, LIFE SCI, V34, P2287, DOI 10.1016/0024-3205(84)90219-4

[7] GOLDSTEIN D, 1985, FED PROC, V44, P1827

[8] HULME EC, 1978, MOL PHARMACOL, V14, P737

[9] LEE JH, 1985, J PHARMACOL EXP THER, V233, P707

[10] ANOMALOUS BINDING OF [H-3] N-METHYLSCOPOLAMINE TO RAT-BRAIN MUSCARINIC RECEPTORS [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 110 (02) : 263 - 266